Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ. McLerran D, et al. Among authors: srivastava s. Clin Chem. 2008 Jan;54(1):44-52. doi: 10.1373/clinchem.2007.091470. Epub 2007 Nov 2. Clin Chem. 2008. PMID: 17981926 Free PMC article.
Diagnostic potential of serum proteomic patterns in prostate cancer.
Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McLeod DG, Moul JW, Srivastava S. Bañez LL, et al. Among authors: srivastava s. J Urol. 2003 Aug;170(2 Pt 1):442-6. doi: 10.1097/01.ju.0000069431.95404.56. J Urol. 2003. PMID: 12853795 Clinical Trial.
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
Grizzle WE, Adam BL, Bigbee WL, Conrads TP, Carroll C, Feng Z, Izbicka E, Jendoubi M, Johnsey D, Kagan J, Leach RJ, McCarthy DB, Semmes OJ, Srivastava S, Srivastava S, Thompson IM, Thornquist MD, Verma M, Zhang Z, Zou Z. Grizzle WE, et al. Among authors: srivastava s. Dis Markers. 2003-2004;19(4-5):185-95. doi: 10.1155/2004/546293. Dis Markers. 2003. PMID: 15258333 Free PMC article.
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L. Semmes OJ, et al. Among authors: srivastava s. Clin Chem. 2005 Jan;51(1):102-12. doi: 10.1373/clinchem.2004.038950. Clin Chem. 2005. PMID: 15613711
Proteomics in prostate cancer.
Bañez LL, Srivastava S, Moul JW. Bañez LL, et al. Among authors: srivastava s. Curr Opin Urol. 2005 May;15(3):151-6. doi: 10.1097/01.mou.0000165547.48922.12. Curr Opin Urol. 2005. PMID: 15815190 Review.
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, Sokoll L, Srivastava S, Srivastava S, Thornquist M, Troyer D, Wright GL, Zhang Z, Zhu L, Semmes OJ. McLerran D, et al. Among authors: srivastava s. Clin Chem. 2008 Jan;54(1):53-60. doi: 10.1373/clinchem.2007.091496. Epub 2007 Nov 16. Clin Chem. 2008. PMID: 18024530 Free PMC article.
Predominance of ERG-negative high-grade prostate cancers in African American men.
Farrell J, Young D, Chen Y, Cullen J, Rosner IL, Kagan J, Srivastava S, McLEOD DG, Sesterhenn IA, Srivastava S, Petrovics G. Farrell J, et al. Among authors: srivastava s. Mol Clin Oncol. 2014 Nov;2(6):982-986. doi: 10.3892/mco.2014.378. Epub 2014 Aug 7. Mol Clin Oncol. 2014. PMID: 25279185 Free PMC article.
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.
He J, Schepmoes AA, Shi T, Wu C, Fillmore TL, Gao Y, Smith RD, Qian WJ, Rodland KD, Liu T, Camp DG 2nd, Rastogi A, Tan SH, Yan W, Mohamed AA, Huang W, Banerjee S, Kagan J, Srivastava S, McLeod DG, Srivastava S, Petrovics G, Dobi A, Srinivasan A. He J, et al. Among authors: srivastava s. J Transl Med. 2015 Feb 12;13:54. doi: 10.1186/s12967-015-0418-z. J Transl Med. 2015. PMID: 25889691 Free PMC article.
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.
Gao Y, Wang YT, Chen Y, Wang H, Young D, Shi T, Song Y, Schepmoes AA, Kuo C, Fillmore TL, Qian WJ, Smith RD, Srivastava S, Kagan J, Dobi A, Sesterhenn IA, Rosner IL, Petrovics G, Rodland KD, Srivastava S, Cullen J, Liu T. Gao Y, et al. Among authors: srivastava s. Cancers (Basel). 2020 May 17;12(5):1268. doi: 10.3390/cancers12051268. Cancers (Basel). 2020. PMID: 32429558 Free PMC article.
6,110 results